Pilianidis, G.; Papanastasiou, G. .; Tikoudi, P. .; Themistocleous, A. .; Farmakis, G. .; Dolianitis, K. . Can Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors Be Avoided in COVID-19 and Other Acute Infections?. EJCRIM 2024, 11.